To summarize recent evidence on dysbiosis, barrier dysfunction, and immunometabolic signaling in the gut–joint axis related to ankylosing spondylitis (AS).
Key Findings:
Remove unsupported phrases about links to AS disease activity.
Interpretation:
Remove unsupported conclusions about AS pathogenesis.
Limitations:
Ensure limitations are directly sourced.
Conclusion:
Revise to avoid suggesting interventions without direct support.
A prespecified exploratory analysis of the FIND-CKD clinical trial examined kidney function, albuminuria, and kidney failure outcomes in 903 patients with glomerular diseases.
